Keywords: R&D spending, European Union, USA,Japan, Pharmaceuticals, Biotechnology

Corporate R&D investment in 2008: a global increase with EU companies leading USA and Japan; Pharma/biotech top sectors

Article | 16 November 2009

Worldwide corporate R&D investment increased by 6.9% in 2008, in spite of the economic crisis, according to the 2009 "European Union Industrial R&D Investment Scoreboard" released today on the European Commission’s web site.

With an 8.1% increase, the R&D investment growth of EU companies, defined as those having headquarters within the EU, is significantly higher than US ones for the second year, at 5.7%, and Japanese firms, at 4.4%. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in